Balanced Body Organics, Inc. is conducting an exempt securities offering valued at $85,000, comprising 102,000 common shares priced at $0.83 per share. For investors, the terms identify the securities being offered and their stated per-share price, while the notice lists the company’s officers and directors responsible for the transaction.
Key Highlights
- The offering covers 102,000 common shares priced at $0.83 per share.
- Sebastian Smith is listed as chairman and chief executive officer.
- John E. Sartore signed the notice as chief financial officer and executive vice president.
Balanced Body Organics, Inc. reported an exempt securities offering of $85,000 on September 10, 2026. The transaction involves common shares, with the stated aggregate price tied to 102,000 shares. Balanced Body Organics lists its address as 101 Lea Avenue, Nashville, Tennessee 37,210, with the telephone number 6,159,889,911.
Common Share Terms and Named Executives
The securities are common shares priced at $0.83 per share, according to the offering terms. Amanda Hester-Smith is listed as an executive officer, director, promoter and president. Andrew John Calvin is named as an executive officer and chief Marketing officer. John E. Sartore signed the notice on behalf of Balanced Body Organics as chief financial officer.
FAQs
Q: What offering amount does the Form D notice report?
A: The filing reports an exempt securities offering with a total offering amount of $85,000. It states that the amount represents 102,000 common shares priced at $0.83 per share.
Q: What address and telephone number does the filing provide?
A: The filing lists 101 Lea Avenue, Nashville, Tennessee 37,210, as the company's address. It provides 6,159,889,911 as the telephone number.
Q: Who signed the Form D notice?
A: John E. Sartore signed the notice for Balanced Body Organics, Inc. The filing identifies him as chief financial officer and executive vice president.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.